ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.3
  1. ホーム
  2. /化合物

アミトリプチリン 塩酸塩

Amitriptyline Hydrochloride

HCID 11065
反応を作成
印刷
基本情報概要名称と識別子物性安全と法規制化学と産業関連反応化合物ノート
部分構造検索類似構造を探す

基本情報

CAS
549-18-8
標準SMILES
CN(C)CCC=C1c2ccccc2CCc2ccccc21.Cl
InChIKey
KFYRPLNVJVHZGT-UHFFFAOYSA-N
分子式
C20H24ClN
平均分子量
313.9 g/mol
単同位体質量
313.1597275

概要

Amitriptyline hydrochloride is an organic tricyclic compound.

名称と識別子

優先名称
Amitriptyline Hydrochloride
IUPAC
N,N-dimethyl-3-(2-tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,11,13-hexaenylidene)propan-1-amine;hydrochloride
現地名
アミトリプチリン 塩酸塩
英語名
Amitriptyline hydrochloride
分子式
C20H24ClN
分子量
313.86

名称と別名

Amitriptyline hydrochloride549-18-8Amitriptyline HClEtravilSyneudonNovoprotectAmitidAmitrilSaroten RetardNIH 10794CytriptylineDTXSID9033187
名称をさらに表示
アミトリプチリン 塩酸塩トリプタノール3-[(10,11-ジヒドロ-5H-ジベンゾ[a,d]シクロヘプテン)-5-イリデン]-N,N-ジメチル-1-プロパンアミン·塩酸塩アミプリン塩酸アミトリプチリンアミトリプチリン塩酸塩アミノトリプチンアミトリプチリン·塩酸塩ノーマルンアミトリプチリン 塩酸塩 溶液アミトリプチリン塩酸塩 (JP17)endepAmitriptyline Hydrochloride (200 mg)deprexNormalnAmiplindomicaletrafonsaroten
Amitriptylini hydrochloridum26LUD4JO9KNSC-1042101-Propanamine, 3-(10,11-dihydro-5H-dibenzo(a,d)cyclohepten-5-ylidene)-N,N-dimethyl-, hydrochlorideDTXCID7013187NSC104210NSC1699101-propanamine, 3-(10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5-ylidene)-N,N-dimethyl-, hydrochloride

データベース識別子

CAS
549-18-8

物性

構造計算による物性

極性表面積
3.2 Ų
水素結合供与体数
1
水素結合受容体数
1
回転可能結合数
3
重原子数
22
形式電荷
0
複雑度
331

実験および物理化学的性質

Solubility>47.1 [ug/mL] (The mean of the results at pH 7.4)
Human Drugs · 2 件

FDA approved drugs -> Active ingredient

FDA approved drugs -> Active ingredient

Collision Cross Section166.3 Ų [M+H]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]

物理化学的性質

融点
196 · 196-197°C
闪点
11 °C · 11 °C
貯蔵温度
2 · 2-8°C
溶解性
2 O: · H2O: 可溶
外見
粉
酸解離定数(Pka)
9.4 · 9.4(at 25℃)
色
ホワイトからオフホワイト
PH
4.5 · 4.5~6.0 (10g/l, 25℃)
水溶解度
ほとんど透明
Merck
14 · 14,487
Henry's Law Constant
1.4 · 1.4×102 mol/(m3Pa) at 25℃, HSDB (2015)
BCS Class
1 · 1
InChI
InChI=1S/C20H23N.ClH/c1-21(2)15-7-12-20-18-10-5-3-8-16(18)13-14-17-9-4-6-11-19(17)20;/h3-6,8-12H,7,13-15H2,1-2H3;1H

安全と法規制

安全情報は参考情報です。供給元の安全データシート(SDS)、適用法令、専門家による評価に代わるものではありません。

GHS分類

GHS Classification · 5 件

This chemical does not meet GHS hazard criteria for 0.7% (1 of 136) of reports.

Danger

H301 (71.3%): Toxic if swallowed [Danger Acute toxicity, oral]

P203, P260, P263, P264, P264+P265, P270, P273, P280, P301+P316, P301+P317, P305+P351+P338, P305+P354+P338, P308+P316, P317, P318, P321, P330, P337+P317, P391, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 136 reports by companies from 21 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

危険有害性情報

Regulatory Information · 2 件

REACH registered substance: Amitriptyline hydrochloride (EC: 208-964-6)

Amitriptyline hydrochloride: Does not have an individual approval but may be used under an appropriate group standard

Other Safety InformationIMAP assessments - 1-Propanamine, 3-(10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5-ylidene)-N,N-dimethyl-, hydrochloride: Human health tier I assessment
Hazard Classes and CategoriesAcute Tox. 3 (71.3%)

毒性情報

Treatment · 1 件

Consider gastric lavage only if within one hour of a potentially fatal overdose. Give 50 grams of charcoal if within one hour of ingestion. Prolonged resuscitation may be successful in case of cardiac arrest. Give sodium bicarbonate in case of arrhythmias. (A311)

Health Effects · 1 件

Some rare side effects include tinnitus, hypotension, mania, psychosis, heart block, arrhythmias, lip and mouth ulcers, extrapyramidal symptoms, depression, and hepatic toxicity.Amitriptyline exhibits strong anticholinergic activity, cardiovascular effects including orthostatic hypotension, changes in heart rhythm and conduction, and a lowering of the seizure threshold (A308, L1032).

化学と産業

薬理情報

Metabolism/Metabolites · 1 件

Amitriptyline is rapidly and well absorbed following oral administration. Exclusively hepatic, with first pass effect. Amitriptyline is demethylated in the liver to its primary active metabolite, nortriptyline. Route of Elimination: Virtually the entire dose is excreted as glucuronide or sulfate conjugate of metabolites, with little unchanged drug appearing in the urine. 25-50% of a single orally administered dose is excreted in urine as inactive metabolites within 24 hours. Small amounts are excreted in feces via biliary elimination. Half Life: 10 to 50 hours, with an average of 15 hours

FDA Pharmacological Classification · 4 件

AMITRIPTYLINE HCL

Tricyclic Antidepressant [EPC]

AMITRIPTYLINE HYDROCHLORIDE

Tricyclic Antidepressant [EPC]

MeSH Pharmacological Classification · 3 件

Substances that contain a fused three-ring moiety and are used in the treatment of depression. These drugs block the uptake of norepinephrine and serotonin into axon terminals and may block some subtypes of serotonin, adrenergic, and histamine receptors. However, the mechanism of their antidepressant effects is not clear because the therapeutic effects usually take weeks to develop and may reflect compensatory changes in the central nervous system.

A subclass of analgesic agents that typically do not bind to OPIOID RECEPTORS and are not addictive. Many non-narcotic analgesics are offered as NONPRESCRIPTION DRUGS.

Drugs that block the transport of adrenergic transmitters into axon terminals or into storage vesicles within terminals. The tricyclic antidepressants (ANTIDEPRESSIVE AGENTS, TRICYCLIC) and amphetamines are among the therapeutically important drugs that may act via inhibition of adrenergic transport. Many of these drugs also block transport of serotonin.

用途と製造

UsesFor the treatment of depression, chronic pain, irritable bowel syndrome, sleep disorders, diabetic neuropathy, agitation and insomnia, and migraine prophylaxis.

関連反応

2 件
反応記録を作成
HRID 990584 の反応式
HRID 990584反応物として
HRID 990585 の反応式
HRID 990585反応物として

化合物ノート

このページの内容基本情報概要名称と識別子物性安全と法規制化学と産業関連反応化合物ノート
PubChem CID
11065
DTXSID
DTXSID9033187
ChEMBL
CHEMBL1200964
ChEBI
CHEBI:2667
UNII
26LUD4JO9K
EC Number
208-964-6
InChIKey
KFYRPLNVJVHZGT-UHFFFAOYSA-N
SMILES
CN(CC/C=C1/C2=C(C=CC=C2)CCC2=C/1C=CC=C2)C.[H]Cl
CAS データベース
549 · 549-18-8(CAS DataBase Reference)
EPAの化学物質情報
Amitriptyline hydrochloride (549-18-8)

化学的性質

化学的特性White to Off-White Solid

Exposure RoutesOral (A308) Rapidly and well absorbed following oral administration (bioavailability is 30-60% due to first pass metabolism). Peak plasma concentrations occur 2-12 hours following oral or intramuscular administration.
Toxicity Summary · 1 件

Amitriptyline is metabolized to nortriptyline which inhibits the reuptake of norepinephrine and serotonin almost equally. Amitriptyline inhibits the membrane pump mechanism responsible for uptake of norepinephrine and serotonin in adrenergic and serotonergic neurons. Pharmacologically this action may potentiate or prolong neuronal activity since reuptake of these biogenic amines is important physiologically in terminating transmitting activity. This interference with the reuptake of norepinephrine and/or serotonin is believed by some to underlie the antidepressant activity of amitriptyline.

Signs and Symptoms · 1 件

Symptoms of overdose include abnormally low blood pressure, confusion, convulsions, dilated pupils and other eye problems, disturbed concentration, drowsiness, hallucinations, impaired heart function, rapid or irregular heartbeat, reduced body temperature, stupor, and unresponsiveness or coma. Side effects include: sedation, hypotension, blurred vision, dry mouth, constipation, urinary retention, postural hypotension, tachycardia, hypertension, ECG changes, heart failure, impaired memory and delirium, and precipitation of hypomanic or manic episodes in bipolar depression. Withdrawal symptoms include gastrointestinal disturbances, anxiety, and insomnia.

Carcinogen ClassificationNo indication of carcinogenicity to humans (not listed by IARC).
Drug Induced Liver Injury · 6 件

Drug Induced Liver Injury Rank (DILIrank 2.0)

Amitriptyline hydrochloride

vLess-DILI-concern

5

Adverse reactions

DOI:10.1016/j.drudis.2016.02.015

Toxicity DataLD50: 350 mg/kg (Oral, Mouse) (A308)

安全データ

wgk
3
tsca
TSCA listed
rtecs
HO9450000
ridadr
UN 2811 6.1/PG 3
毒性
LD50 in mice, rats (mg/kg): 350, 380 orally; 65, 75 i.p. (Tobe)
hs_code
29214990
risk_code
23/24/25-36/37/38-42/43-63-39/23/24/25-11-50/53-36-22
hazard_code
T,F,N,Xn
safety_code
22-26-36/37/39-45-36/37-16-61-60-7
hazard_class
6.1(b)
packing_group
III
Hazard Classifications
Acute Tox. 3 OralAquatic Acute 1Aquatic Chronic 1Eye Irrit. 2Repr. 2
ストレージクラス
6.1C - Combustible acute toxic Cat.3toxic compounds or compounds which causing chronic effects
General Manufacturing Information1-Propanamine, 3-(10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5-ylidene)-N,N-dimethyl-, hydrochloride (1:1): INACTIVE
応用分野 · 4 件

用途薬理研究用。

説明Amitriptyline (hydrochloride) (CRM) (Item No. 19031) is a certified reference material categorized as a tricyclic antidepressant. This product is intended for analytical forensic applications. This product is also available as a general research tool .

使用Amitriptyline hydrochloride is a tricyclic antidepressant drug. Amitriptyline hydrochloride inhibits the norepinephrine and serotonin transporters but has a high affinity for α1-adrenergic, serotonin and muscarinic acetylcholine receptors.

一般的な説明Amitriptyline, 3-(10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5-ylidene)-N,N-dimethyl-1-propanamine hydrochloride,5-(3-dimethylaminopropylidene)-10,11-dihydro-5Hdibenzo[a,d]cycloheptene hydrochloride (Elavil), is one ofthe most anticholinergic and sedative of the TCAs. Becauseit lacks the ring-electron–enriching nitrogen atom ofimipramine, metabolic inactivation mainly proceeds not at theanalogous 2-position but at the benzylic 10-position (i.e.,toluene-like metabolism predominates). Because of the 5-exocyclic double bond, E- and Z-hydroxy isomers are producedby oxidation metabolism. Conjugation produces excretablemetabolites. As is typical of the dimethyl compounds,N-demethylation occurs, and nortriptyline is produced, whichhas a less anticholinergic, less sedative, and more stimulantaction than amitriptyline. Nortriptyline is a SNERI; thecomposite action of drug and metabolite is nonselective.

上流・下流製品情報

上流原料

ジケテンアミトリプチリンジエチルエーテル (無水)塩化アンモニウムDilute hydrochloric acid酸化りん(V)フェニル酢酸水素塩酸フタル酸無水物N,N-ジメチル-3-クロロ-1-プロパンアミン